Stable Isotope Labeled Compounds Market Share, Size, Trends, Industry Analysis Report, By Type (Carbon 13, Deuterium, Oxygen 18, Nitrogen 15); By Application; By End Use; By Region; Segment Forecast, 2023 - 2032
- Published Date:Jun-2023
- Pages: 115
- Format: PDF
- Report ID: PM3352
- Base Year: 2022
- Historical Data: 2019-2021
Report Outlook
The global stable isotope labeled compounds market was valued at USD 283.19 million in 2022 and is expected to grow at a CAGR of 3.4% during the forecast period. Stable isotope labeled compounds are used in medical imaging techniques to diagnose cancer. These techniques are highly sensitive and accurate, and enable early detection of cancer, leading to better treatment outcomes. According to the American Cancer Society, with projected numbers of cancer deaths and new cases in the United States, there will be 609,360 cancer deaths and an estimated 1.9 million new cancer cases in 2022. This will further fuel the growth of the market in upcoming years. Many governments around the world are increasing their funding for cancer research, leading to a growing demand for stable isotope labeled compounds in cancer research.
To Understand More About this Research: Request a Free Sample Report
India's increasing pharmaceutical exports are positively influencing the growth of the stable isotope labeled compounds market. Stable isotope labeling is a crucial process in drug discovery and development, as it allows researchers to track the metabolism, distribution, and elimination of a drug candidate in vivo. Indian pharmaceutical exports increased by 103% between 2013–14 and 2021–22, from Rs. 90, 415 Crores to Rs. 1,83, 422 Crores. The Pharma Sector's export performance was at its highest level ever in 2021–22. Exports have increased by approximately $10 billion in just 8 years, which is a tremendous gain.
With India's pharmaceutical industry growing at a rapid pace, the demand for stable isotope labeled compounds is also increasing. This has led to the development of a vibrant stable isotope labeling ecosystem in India, with several companies offering custom synthesis and labeling services to pharmaceutical companies. USA, UK, South Africa, Russia, and Nigeria are India's top 5 international markets for pharmaceutical exports.
For Specific Research Requirements, Request for a Customized Report
Industry Dynamics
Growth Drivers
The pharmaceutical industry is one of the primary end-users of stable isotope labeled compounds. The growing demand for new drug development and clinical research is expected to drive the demand for stable isotope labeled compounds. The increasing focus on personalized medicine is expected to drive the demand for stable isotope labeled compounds. These compounds are used in drug discovery and development, clinical research, and diagnostic applications, which are essential components of personalized medicine.
The development of advanced analytical technologies, such as mass spectrometry, has significantly improved the accuracy and sensitivity of stable isotope analysis. This has led to increased adoption of such isotopes in several applications, including proteomics, metabolomics, and lipidomics. The increasing awareness about environmental pollution and the need for sustainable practices are expected to drive the demand for stable isotope labeled compounds in environmental testing applications, including water and soil analysis.
The prevalence of cancer globally is expected to drive the demand for labeled compounds in cancer research and diagnosis. These compounds are used in imaging and therapeutic applications, including positron emission tomography (PET) imaging and targeted therapy.
Report Segmentation
The market is primarily segmented based on type, application, end user and region.
|
By Type |
By Application |
By End User |
By Region |
|
|
|
|
To Understand the Scope of this Report: Speak to Analyst
Carbon 13 segment is expected to witness fastest growth over the forecast period
Carbon-13 labeling is also used in proteomics, metabolomics, and lipidomics, which are critical for the development of personalized medicine. The increasing focus on personalized medicine is expected to drive the demand for carbon-13 labeled compounds.
Moreover, the use of carbon-13 labeled compounds in environmental testing for water and soil analysis has gained significant attention in recent years due to increasing awareness about environmental pollution and the need for sustainable practices. The development of advanced analytical technologies, such as mass spectrometry, has significantly improved the accuracy and sensitivity of carbon-13 analysis. This has led to increased adoption of carbon-13 labeled compounds in various applications, including proteomics, metabolomics, and lipidomics.
The research segment accounted for the largest market share in 2022
The rising availability of research funding for various fields, including pharmaceuticals, biotechnology, and environmental testing, is driving the demand for stable isotope labeled compounds. This funding is often used to support research studies that require stable isotope labeling. The pharmaceutical industry is a significant user of stable isotope labeled compounds, as they play a critical role in drug discovery and development. As the demand for new drugs continues to grow, the demand for stable isotope labeled compounds is also expected to increase.
Stable isotope labeled compounds are widely used in the discovery of biomarkers, which are critical for disease diagnosis and treatment. The increasing use of stable isotope labeled compounds in biomarker discovery is expected to drive the growth of the research segment in the market.
Pharmaceutical and biotechnology companies are expected to hold the significant revenue share
Increasing focus on personalized medicine is expected to drive the demand for stable isotope labeled compounds. These compounds are used in proteomics, metabolomics, and lipidomics, which are critical for the development of personalized medicine. Stable isotope labeled compounds are widely used in drug discovery and development, particularly in the pharmaceutical industry. These compounds help to differentiate between various compounds and study metabolic pathways in living organisms, which is critical for drug development. As the demand for new drugs continues to grow, the demand for stable isotope labeled compounds is also expected to increase.
The demand in Asia Pacific is expected to witness significant growth over the forecast period
Asia Pacific is projected to experience a higher growth rate in coming years as it is witnessing a growing focus on environmental testing, particularly in areas such as water and soil analysis. The combination of climate change and the increasing demand for clean energy sources is driving the growth of the stable isotope labeled compounds market in this region. Climate change will have a considerable impact on growth in the Asia-Pacific region. Without addressing climate change, the region's GDP might fall by as much as 3.3% by 2050 and 10% by 2100 compared to the base case.
North America is expected to dominate the revenue share throughout the forecast period. It has an established healthcare infrastructure, with a high level of healthcare expenditure and many healthcare facilities. This has led to a growing demand for stable isotope labeled compounds in diagnostic testing and medical research. In terms of health care spending, the United States is the top nation in the world. The United States spent more than USD 4 trillion on healthcare overall in 2020. According to Statista, By the year 2028, it is anticipated that expenditure as a share of GDP will rise to about 20 percent.
Competitive Insight
Some of the major players operating in the global market include PerkinElmer, Merck, Cambridge Isotope Laboratories, JSC Isotope, Medical Isotopes, Omicron Biochemicals, Trace Sciences, Taiyo Nippon Sanso.
Recent Developments
- In February 2023, PerkinElmer introduced The EnVision NexusTM system, the fastest multi-mode plate reader. It was created for demanding the HTS applications & to speed up the efforts required in drug discovery.
- In November 2022, Biotheus a Chinese biotech business specializing in the development of cancer and autoimmune disease therapies, and Merck, a well-known science and technology company, are in partnership. The turn-around of its cell line characterization decreased from 60 to 14 days by utilizing Merck's Rodent Panel.
Stable Isotope Labeled Compounds Market Report Scope
|
Report Attributes |
Details |
|
Market size value in 2023 |
USD 292.26 million |
|
Revenue forecast in 2032 |
USD 394.86 million |
|
CAGR |
3.4% from 2023- 2032 |
|
Base year |
2022 |
|
Historical data |
2019- 2021 |
|
Forecast period |
2023- 2032 |
|
Quantitative units |
Revenue in USD million and CAGR from 2023 to 2032 |
|
Segments Covered |
By Type, By Application, By End User, By Region |
|
Regional scope |
North America, Europe, Asia Pacific, Latin America; Middle East & Africa |
|
Key Companies |
PerkinElmer, Merck KGaA, Cambridge Isotope Laboratories, JSC Isotope, Medical Isotopes, Omicron Biochemicals, Trace Sciences International, Taiyo Nippon Sanso Corporation. |
FAQ's
key companies in stable isotope labeled compounds market are PerkinElmer, Merck, Cambridge Isotope Laboratories, JSC Isotope, Medical Isotopes, Omicron Biochemicals, Trace Sciences, Taiyo Nippon Sanso Corporation.
The global stable isotope labeled compounds market expected to grow at a CAGR of 3.4% during the forecast period.
The stable isotope labeled compounds market report covering key segments are type, application, end user and region.
key driving factors in stable isotope labeled compounds market are growing demand for new drug development and clinical research.
The global stable isotope labeled compounds market size is expected to reach USD 394.86 million by 2032.
